Heart Attack Diagnostics Market - Top Companies and Manufacturers

  • Report ID: 4446
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Companies Dominating the Heart Attack Diagnostics Market

    • Abbott Laboratories
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • ACS Diagnostics, Company
    • Asahi Kasei Corporation
    • AstraZeneca PLC
    • Beckman Coulter, Inc.
    • Hill-Rom Services, Inc
    • Koninklijke Philips N.V.
    • General Electric Company
    • Toshiba Corporation
    • Schiller Americas, inc.  

Browse Key Market Insights with Data Illustration:

In the News

  • General Electric Company, a global leader in medical technology, diagnostics and digital solutions, has launched the first AI-enabled Cath lab made in India - Optima IGS 320, enabling cardiac care in India. The lab is located at the new factory of Wipro GE Healthcare in Bengaluru. The managing director of the company further suggested that AI has the requisite potential to enhance the care pathway.  

  • Abbott Laboratories to received CE marking for its first troponin test that may be able to allow prediction of heart attacks months in advance in apparently healthy adults. It can help the physicians to determine necessary medical steps to prevent heart diseases.


Author Credits:  Radhika Pawar


  • Report ID: 4446
  • Published Date: Oct 11, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of heart attack diagnostics is estimated at USD 14.97 billion.

The heart attack diagnostics market size was over USD 14.06 billion in 2024 and is set to cross USD 38.6 billion by the end of 2037, witnessing more than 8.1% CAGR during the forecast period i.e., between 2025-2037. Rise in geriatric population worldwide and prevalence of unhealthy lifestyles among people will drive the market growth.

North America industry is predicted to dominate majority revenue share by 2037, owing to rising incidence of cardiac diseases along with huge spending on healthcare infrastructure by the regional government and other organization that are helpful to facilitate diagnostic equipment at healthcare facilities.

The major players in the market include Abbott Laboratories, ACS Diagnostics, Company, Asahi Kasei Corporation, AstraZeneca PLC, Beckman Coulter, Inc., Hill-Rom Services, Inc, Koninklijke Philips N.V., General Electric Company, Toshiba Corporation, Schiller Americas, inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample